Stevanato Group S.p.A STVN
NYSE STVN
$22.60 +0.25 (+1.12%)
At close: Aug 21, 2026 · 4:00 PM EDT

Stevanato Group S.p.A (STVN) Net Income towards Common Stockholders (2020 - 2026)

Stevanato Group S.p.A (STVN) posted quarterly Net Income towards Common Stockholders of $0.12 for Q1 2026, up 11.3% year-over-year from $0.11 in Q1 2025, and down 100.0% quarter-over-quarter from $55.4 million in Q4 2025.

Stevanato Group S.p.A (STVN) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends

Stevanato Group S.p.A (STVN) has reported Net Income towards Common Stockholders for 7 consecutive years, with $0.12 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Net Income towards Common Stockholders rose 11.3% year-over-year to $0.12; the TTM figure through Mar 2026 stood at $55.4 million (up 7.22% YoY), while the FY2025 annual figure was $162.8 million, up 29.34% from the prior year.
  • Net Income towards Common Stockholders retreated to $0.12 in Q1 2026 per STVN's latest filing, from $55.4 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $55.4 million in Q4 2025 and bottomed at $0.08 in Q1 2024.
  • Historically, Net Income towards Common Stockholders has averaged $18.0 million across 5 years, with a median of $0.15 in 2025.
  • Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders soared 65.99% — and 2023, when it tumbled 100.0%.
  • Stevanato Group S.p.A's Net Income towards Common Stockholders stood at $49.4 million in 2022, then retreated by 1.41% to $48.7 million in 2023, then increased by 6.08% to $51.6 million in 2024, then grew by 7.22% to $55.4 million in 2025, then tumbled by 100.0% to $0.12 in 2026.
  • Business Quant data shows STVN's Net Income towards Common Stockholders at $0.12 in Q1 2026, $55.4 million in Q4 2025, and $0.15 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 823.20 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 378.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 383.43 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 139.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 147.90 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 93.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -77.90 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 126.00 Mn
10 Stevanato Group S.p.A 6.18 Bn 6.07 Bn 100.91 Mn 0.09

Historic Data

Download Data
DateValue
Jun 30, 2026 0.09
Mar 31, 2026 0.12
Dec 31, 2025 55.36 Mn
Sep 30, 2025 0.15
Jun 30, 2025 0.12
Mar 31, 2025 0.11
Dec 31, 2024 51.63 Mn
Sep 30, 2024 0.12
Jun 30, 2024 0.09
Mar 31, 2024 0.08
Dec 31, 2023 48.67 Mn
Sep 30, 2023 0.15
Jun 30, 2023 0.14
Mar 31, 2023 0.12
Dec 31, 2022 49.36 Mn
Sep 30, 2022 36.51 Mn
Jun 30, 2022 32.58 Mn
Mar 31, 2022 31.11 Mn
Dec 31, 2021 51.11 Mn
Sep 30, 2021 22.00 Mn